Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$102.72 USD

102.72
7,656,647

-0.24 (-0.23%)

Updated Jul 16, 2024 04:00 PM ET

After-Market: $102.67 -0.05 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (157 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Bryan Hayes headshot

Medical Devices ETF Hits 52-Week High: Stocks to Watch

by Bryan Hayes

Historically viewed as a defensive area, health care also boasts many growth aspects and benefits from advances in technology.

Roche (RHHBY) Launches AI-Based Predictive CGM Accu-Chek

by Zacks Equity Research

Roche (RHHBY) is likely to enter the growing diabetes market with its AI-enabled predictive glucose monitoring system that may revolutionize diabetes management.

Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note

by Zacks Equity Research

In the closing of the recent trading day, Abbott (ABT) stood at $120.76, denoting a +0.47% change from the preceding trading day.

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note

by Zacks Equity Research

In the most recent trading session, Abbott (ABT) closed at $120.19, indicating a -0.64% shift from the previous trading day.

Abbott (ABT) to Reduce Childhood Malnutrition With New Pact

by Zacks Equity Research

Abbott's (ABT) latest partnership supports its sustainability goal of transforming care for malnutrition and improving the lives of 3 billion people per year by the decade's end.

Why Abbott (ABT) Dipped More Than Broader Market Today

by Zacks Equity Research

In the most recent trading session, Abbott (ABT) closed at $118.48, indicating a -1.3% shift from the previous trading day.

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

by Zacks Equity Research

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Abbott (ABT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the closing of the recent trading day, Abbott (ABT) stood at $120.05, denoting a +0.54% change from the preceding trading day.

Abbott (ABT) Up 5.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Zacks Analyst Blog Highlights Microsoft, Amazon.com, Berkshire Hathaway, Abbott and BlackRock

by Zacks Equity Research

Microsoft, Amazon.com, Berkshire Hathaway, Abbott and BlackRock are included in this Analyst Blog.

Abbott (ABT) Increases Yet Falls Behind Market: What Investors Need to Know

by Zacks Equity Research

In the most recent trading session, Abbott (ABT) closed at $119.02, indicating a +0.98% shift from the previous trading day.

Mark Vickery headshot

Top Analyst Reports for Microsoft, Amazon.com & Berkshire Hathaway

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Amazon.com, Inc. (AMZN) and Berkshire Hathaway Inc. (BRK.B).

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for PJP

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for NOBL

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Insulet's (PODD) Omnipod 5 Gets CE Mark for Added Compatibility

by Zacks Equity Research

Insulet's (PODD) tubeless automated insulin delivery system's CE mark approval with multiple CGM sensor brands is likely to serve a wider patient pool.

HAE vs. ABT: Which Stock Is the Better Value Option?

by Zacks Equity Research

HAE vs. ABT: Which Stock Is the Better Value Option?

Sheraz Mian headshot

Top Research Reports for Abbott, T-Mobile & Booking

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Abbott (ABT) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.

Manufacturing Numbers Expected After Opening Bell

by Zacks Equity Research

Manufacturing Numbers Expected After Opening Bell.

Abbott's (ABT) Q4 Earnings Match Estimates, Margins Rise

by Zacks Equity Research

Abbott (ABT) delivers better-than-expected revenues and in-line earnings for the fourth quarter of 2023.

Mark Vickery headshot

Q4 Earnings Roundup: ABT, GD, KMB & More

by Mark Vickery

A spot-check of early morning Q4 reports show some earnings misses and revenue beats; Tesla and others report after the close.